From ESMO GI 2026 to Global Cancer Control: Major Updates in GI Oncology
Jul 15, 2026
View online
WHO Global Cancer Report 2026: GI Cancers Show the Cost of Delayed Prevention, Diagnosis, and Access
Agenus Announces Up to $340M Financing to Advance Phase 3 ROBBIN of Neoadjuvant BOT/BAL in MSS Colon Cancer
Highlights of ESMO GI 2026 in Colorectal Cancer with Davide Ciardiello
Daraxonrasib for Pancreatic Cancer: What’s Next?
PICC-2: Toripalimab Plus Celecoxib Improves pCR in dMMR Locally Advanced Colorectal Cancer
Top 10 Pancreatic Cancer Updates – June 2026
20 Posts Not To Miss From ESMO GI 2026, Part 1
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
